Lv0
0 积分 2025-12-02 加入
Lipid-lowering drug treatment and mortality among individuals ≥75 years without cardiovascular disease: a population-based cohort study
12天前
已完结
Remnant cholesterol and low-grade inflammation jointly in atherosclerotic cardiovascular disease: implications for clinical trials
6个月前
已完结
From Cushion to Culprit: The Role of Epicardial Adipose Tissue in Cardiovascular Disease
7个月前
已完结
Epicardial adipose tissue in contemporary cardiology
7个月前
已完结
Epicardial adipose tissue and new-onset atrial fibrillation in a Danish cohort
8个月前
已完结
Periatrial Epicardial Fat and Atrial Fibrillation
8个月前
已完结
Safety outcomes of SGLT2i in the heart failure trials: A systematic review and Meta-analysis
8个月前
已完结
Sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) plus glucagon‐like peptide type 1 receptor combination is more effective than SGLT2i plus dipeptidyl peptidase‐4 inhibitor combination in treating obese mice metabolic dysfunction‐associated steatotic liver disease (MASLD)
8个月前
已完结
Perspective on Epicardial Adipose tissue
8个月前
已完结
Cardio-Lipotoxicity of Epicardial Adipose Tissue
8个月前
已完结
皖公网安备34019202002308
